NR3C1 and carcinoma: The same mechanisms that are induced in lymphoid cells are blocked in several carcinoma cells by GCs thereby inhibiting chemo- and radiation therapy-induced apoptosis [14,15].An open question is, how GCs mediate these cell-type specific effects clearly shown to be related to a functional glucocorticoid receptor (GR) [14,15].